Long QT Syndrome 5: The Promise of Genetic Testing in Precision Medicine
Explore how genetic testing enhances diagnosis and management of Long QT Syndrome 5, offering personalized treatment and informed family planning choices.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Long QT Syndrome 6: Unlocking the Mysteries with Genetic Testing
Explore how genetic testing revolutionizes Long QT Syndrome 6 management by identifying mutations, guiding treatments, and enhancing genotype-phenotype insights.
Lymphedema-Posterior Choanal Atresia Syndrome: Unlocking the Genetic Code
Explore how genetic testing helps diagnose Lymphedema-Posterior Choanal Atresia Syndrome by identifying PTPN14 mutations, enabling early intervention and family planning.
Mapping the Mysteries: Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A and Genetic Testing
Explore the role of genetic testing in diagnosing MLC2A, a neurological disorder, for early intervention, personalized care, and informed family planning strategies.
Megalencephalic Leukoencephalopathy with Subcortical Cysts 2B: A Genetic Insight
Explore the genetic roots of MLC2B, a rare brain disorder. Discover how genetic testing aids in diagnosis, management, and family planning for better outcomes.
Molecular Mysteries: Unraveling Meier-Gorlin Syndrome 2 Through Genetic Testing
Explore how genetic testing advances our understanding of Meier-Gorlin Syndrome 2, offering insights into diagnosis, management, and potential targeted therapies.
Mapping the Mysteries: Genetic Testing in Meier-Gorlin Syndrome 3
Explore how genetic testing aids in diagnosing Meier-Gorlin Syndrome 3, uncovering genotype-phenotype links, and supporting family planning and therapeutic advancements.
Mapping the Mysteries: Genetic Testing and Meier-Gorlin Syndrome 4
Explore how genetic testing aids in diagnosing Meier-Gorlin Syndrome 4, enabling early intervention, personalized treatments, and informed family planning decisions.